NeoPharm Co (XKRX:092730) Accounts Payable & Accrued Expense : ₩20,791 Mil (As of Mar. 2024)

View and export this data going back to 2007. Start your Free Trial

What is NeoPharm Co Accounts Payable & Accrued Expense?

NeoPharm Co's quarterly accounts payable & accrued expense increased from Sep. 2023 (₩14,223 Mil) to Dec. 2023 (₩14,736 Mil) and increased from Dec. 2023 (₩14,736 Mil) to Mar. 2024 (₩20,791 Mil).

NeoPharm Co's annual accounts payable & accrued expense increased from Dec. 2021 (₩11,360 Mil) to Dec. 2022 (₩11,554 Mil) and increased from Dec. 2022 (₩11,554 Mil) to Dec. 2023 (₩14,736 Mil).

NeoPharm Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for NeoPharm Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NeoPharm Co Accounts Payable & Accrued Expense Chart

NeoPharm Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

10,952.19

9,733.97

11,359.55

11,553.62

14,735.97

NeoPharm Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															17,738.07	11,722.92	14,223.05	14,735.97	20,791.18

NeoPharm Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

NeoPharm Co (XKRX:092730) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » NeoPharm Co Ltd (XKRX:092730) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

928 Tamnip-dong, Yuseong-gu, Daejon, KOR, 305-510

Website

http://www.neopharm.co.kr

NeoPharm Co Ltd is a South Korean company operating in the household and personal products. The products of the company include skin care brand, skin barrier special dermo cosmetic brand, hospital functional products, and life moisturizing body professional brand.

NeoPharm Co (XKRX:092730) Headlines

No Headlines